Wendy W Unger Selected Research

sulfo-Lewis(a)

4/2011

Design of neo-glycoconjugates that target the mannose receptor and enhance TLR-independent cross-presentation and Th1 polarization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wendy W Unger Research Topics

Disease

3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2011 - 10/2008
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Infections 01/2021
1	Inflammation (Inflammations) 01/2018
1	Neoplasms (Cancer) 04/2011
1	Hyperglycemia 10/2008

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 11/2011 - 10/2008
1	InterferonsIBA 01/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2021
1	Interferon-betaIBA 01/2021
1	GlycosyltransferasesIBA 01/2018
1	Histocompatibility Antigens Class IIBA 04/2011
1	AntigensIBA 04/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2011
1	sulfo-Lewis(a)IBA 04/2011
1	Mannose ReceptorIBA 04/2011
1	N,N',N''-triacetylchitotrioseIBA 04/2011
1	EpitopesIBA 10/2008
1	Glucose (Dextrose)FDA LinkGeneric 10/2008
1	preproinsulinIBA 10/2008

Therapy/Procedure

1	Therapeutics 10/2008